Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS

ERR1524285 E-MTAB-4921:MEM001 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595244 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524286 E-MTAB-4921:MEM002 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595245 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524287 E-MTAB-4921:MEM005 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595246 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524288 E-MTAB-4921:MEM007 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595247 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524289 E-MTAB-4921:MEM009 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595248 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524290 E-MTAB-4921:MEM011 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595249 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524291 E-MTAB-4921:MEM011_N1 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595250 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524292 E-MTAB-4921:MEM012 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595251 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2019-01-24 ERR1524293 E-MTAB-4921:MEM012_N1 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595252 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524294 E-MTAB-4921:MEM013 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595253 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2019-01-24 ERR1524295 E-MTAB-4921:MEM013_N1 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595254 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524296 E-MTAB-4921:MEM014 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595255 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524297 E-MTAB-4921:MEM015 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595256 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524298 E-MTAB-4921:MEM016 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595257 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524299 E-MTAB-4921:MEM017 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595258 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524300 E-MTAB-4921:MEM018 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595259 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524301 E-MTAB-4921:MEM019 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595260 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524302 E-MTAB-4921:MEM021 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595261 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524303 E-MTAB-4921:MEM022 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595262 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2019-01-24 ERR1524304 E-MTAB-4921:MEM023 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595263 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524305 E-MTAB-4921:MEM023_1 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595263 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524306 E-MTAB-4921:MEM024 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595264 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524307 E-MTAB-4921:MEM025 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595265 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524308 E-MTAB-4921:MEM026 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595266 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2019-01-24 ERR1524309 E-MTAB-4921:MEM027 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595267 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524310 E-MTAB-4921:MEM028 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595268 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524311 E-MTAB-4921:MEM028_1 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595268 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524312 E-MTAB-4921:MEM029 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595269 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524313 E-MTAB-4921:MEM029_1 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595269 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524314 E-MTAB-4921:MEM029_2 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595269 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524315 E-MTAB-4921:MEM030 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595270 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524316 E-MTAB-4921:MEM030_1 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595270 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524317 E-MTAB-4921:MEM030_2 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595270 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524318 E-MTAB-4921:MEM031 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595271 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2019-01-24 ERR1524319 E-MTAB-4921:MEM032 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595272 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2019-01-24 ERR1524320 E-MTAB-4921:MEM033 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595273 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524321 E-MTAB-4921:MEM034 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595274 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524322 E-MTAB-4921:MEM035 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595275 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524323 E-MTAB-4921:MEM035_1 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595275 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524324 E-MTAB-4921:MEM036 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595276 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2019-01-24 ERR1524325 E-MTAB-4921:MEM036_1 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595276 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524326 E-MTAB-4921:MEM037 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595277 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524327 E-MTAB-4921:MEM037_1 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595277 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524328 E-MTAB-4921:MEM037_2 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595277 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524329 E-MTAB-4921:MEM038 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595278 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524330 E-MTAB-4921:MEM039 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595279 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2019-01-24 ERR1524331 E-MTAB-4921:MEM040 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595280 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524332 E-MTAB-4921:MEM040_1 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595280 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524333 E-MTAB-4921:MEM040_2 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595280 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524334 E-MTAB-4921:MEM041 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595281 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524335 E-MTAB-4921:MEM041_1 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595281 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2019-01-24 ERR1524336 E-MTAB-4921:MEM041_2 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595281 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524337 E-MTAB-4921:MEM041_3 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595281 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524338 E-MTAB-4921:MEM042 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595282 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524339 E-MTAB-4921:MEM042_1 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595282 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2019-01-24 ERR1524340 E-MTAB-4921:MEM042_2 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595282 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2019-01-24 ERR1524341 E-MTAB-4921:MEM043 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595283 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524342 E-MTAB-4921:MEM044 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595284 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524343 E-MTAB-4921:MEM044_1 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595284 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2019-01-24 ERR1524344 E-MTAB-4921:MEM044_2 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595284 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524345 E-MTAB-4921:MEM044_3 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595284 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2019-01-24 ERR1524346 E-MTAB-4921:MEM045 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595285 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524347 E-MTAB-4921:MEM046 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595286 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524348 E-MTAB-4921:MEM046_1 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595286 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524349 E-MTAB-4921:MEM046_2 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595286 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524350 E-MTAB-4921:MEM047 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595287 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524351 E-MTAB-4921:MEM047_1 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595287 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2019-01-24 ERR1524352 E-MTAB-4921:MEM047_2 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595287 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524353 E-MTAB-4921:MEM048 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595288 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2019-01-24 ERR1524354 E-MTAB-4921:MEM048_1 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595288 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524355 E-MTAB-4921:MEM048_2 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595288 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2019-01-24 ERR1524356 E-MTAB-4921:MEM048_3 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595288 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524357 E-MTAB-4921:MEM049 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595289 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524358 E-MTAB-4921:MEM050 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595290 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524359 E-MTAB-4921:MEM051 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595291 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524360 E-MTAB-4921:MEM052 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595292 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524361 E-MTAB-4921:MEM053 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595293 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2019-01-24 ERR1524362 E-MTAB-4921:MEM054 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595294 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524363 E-MTAB-4921:MEM055 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595295 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524364 E-MTAB-4921:MEM056 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595296 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524365 E-MTAB-4921:MEM057 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595297 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524366 E-MTAB-4921:MEM058 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595298 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524367 E-MTAB-4921:MEM059 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595299 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524368 E-MTAB-4921:MEM060 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595300 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524369 E-MTAB-4921:MEM061 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595301 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524370 E-MTAB-4921:MEM062 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595302 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2019-01-24 ERR1524371 E-MTAB-4921:MEM065 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595303 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524372 E-MTAB-4921:MEM066 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595304 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524373 E-MTAB-4921:MEM067 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595305 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524374 E-MTAB-4921:MEM076 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595306 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524375 E-MTAB-4921:MEM077 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595307 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524376 E-MTAB-4921:MEM078 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595308 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524377 E-MTAB-4921:MEM090 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595309 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524378 E-MTAB-4921:MEM091 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595310 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16 ERR1524379 E-MTAB-4921:MEM092 Illumina HiSeq 2500 sequencing; Integrative and comparative genomics identifies the tyrosine kinase FES as a key melanoma tumor supppressor: WGS ERX1595311 ENA-FIRST-PUBLIC 2017-05-04 ENA-LAST-UPDATE 2018-11-16